Sign in
CompletedNo phase

Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy

Key facts

Who runs it
George Washington University
Where
Washington D.C., United StatesSee the site
Trial code
Status
Completed
People taking part
55 people enrolled
Started
10 Jun 2022
Ended
11 Feb 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy
Record updated
14 April 2026

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Radiologic evidence of mediastinal and/or hilar lymphadenopathy
  • Attending radiologist or pulmonologist reports a possible diagnosis of sarcoidosis
  • Age 18 years or older

Who cannot take part

  • Previously diagnosed sarcoidosis
  • Severe pulmonary hypertension
  • Severe coagulopathy or bleeding diathesis
  • Acute Hypercarbic Respiratory Failure (pCO2 >55mmHg)
  • These are the characteristics that a participant must NOT have in order to be eligible to participate in the study
  • Order Number Criteria
  • Inability to undergo general anesthesia
  • Patient presently taking clopidogrel
  • Patient deemed to be high risk for general anesthesia per anesthesiologist
  • Hemodynamic instability
  • Mediastinitis

Where in United States

  • The George Washington University HospitalWashington D.C., United States

About the trial

What the trial wants to find out

The investigators will compare endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) with intranodal forceps biopsy (EBUS-IFB) as it relates to the rate of diagnosis of suspected sarcoidosis.

The 2 groups in the trial

  • EBUS-TBNAExisting treatment, for comparison

    These will be the patient who undergo EBUS-TBNA only without EBUS-IFB

    Treatment: Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy

  • EBUS-TBNA + EBUS-IFBTreatment being tested

    These will be the individuals who undergo EBUS-TBNA followed by EBUS-IFB in the same procedure

    Treatment: Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating the Diagnostic Yield and Specimen Quality With Endobronchial Ultrasound-Guided Intranodal Forceps Biopsies in Patients With Mediastinal and Hilar Lymphadenopathy: A Prospective Analysis
Record updated
14 April 2026